| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Strategy &Innovation | EVP Bus. &Corp. Development | SVP Bus. &Corp. Development
1 company
Robin Sherrington is an EVP, Strategy &Innovation at Xenon Pharmaceuticals Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $545K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | XENE Xenon Pharmaceuticals Inc. | EVP, Strategy &Innovation | Sale+OE | 7,137 | $46.28 | $330,290.25 | -23.7% | -17.3% | -20.9% | |
| Sep 1, 2022 | XENE Xenon Pharmaceuticals Inc. | EVP, Strategy &Innovation | Sale+OE | 65,231 | $38.31 | $2,499,022.53 | -52.4% | -6.7% | +0.5% | |
| Mar 4, 2022 | XENE Xenon Pharmaceuticals Inc. | EVP, Strategy &Innovation | Sale+OE | 21,710 | $30.50 | $662,207.60 | -18.0% | -7.4% | +22.4% | |
| May 28, 2021 | XENE Xenon Pharmaceuticals Inc. | EVP, Strategy &Innovation | Sale+OE | 6,067 | $18.81 | $114,120.27 | -8.3% | -8.0% | +48.8% |